In the field of qualitative research, life stories are consolidated as one of the most important techniques within the biographical method. However, due to the multiplicity of techniques covered by this method and the disciplines in which it is applied, the contributions and scope of life histories do not present a clear delimitation. By contrast, a considerable conceptual confusion persists and the transfer of its production remains very narrow. In this sense, this article aims to clarify the field of knowledge generated through life stories. To this end, it innovatively applies the bibliometric method. Making use of performance analysis and scientific mapping through the VosViewer application, it studies a body of 2670 articles indexed in the Web of Science. The results show how knowledge transferred from psychology through its major schools of thought occupies a central place. This leaves in a secondary position the knowledge produced by other disciplines such as sociology or anthropology, which is not transferred in the main forums of scientific impact. In this way, the conclusion points to the need to open up new lines of research to find out the differences between the different techniques and disciplines when applying this methodology.
Research studies show a strong influence of socioeconomic status (SES) on human development, and how the exposure to risk contexts in the earliest stages translates into dangers in the cognitive development of children and adolescents. To alleviate these consequences and favour development, different cognitive training programs have contributed to this field by identifying the criteria of efficacy. This systematic review identifies and synthesizes the evidence of cognitive intervention studies implemented with psychosocial risk groups carried out in Spain. The search strategy was adapted to different databases. Only studies published in English or Spanish and developed in Spain that included interventions applied in populations aged 5 to 18 years with a low SES were included. The analysis of the literature showed nine interventions that indicated an improvement in those cognitive functions worked with low SES children. The cognitive domains that most worked were executive functions, followed by social cognition and language. After reviewing the available literature, a clear scarcity of interventions carried out in Spain was observed. Variables such as age, cognitive functions or personal vulnerability were identified as factors to be taken into account in future lines of research due to their influence on minors. These findings indicate the relevance of this review to help decision-making in relation to the actions to be carried out by the competent bodies in Spain.
Background: Plasma phosphorylated tau at threonine 217 (p-tau217) has emerged as a leading blood-based biomarker for the diagnosis of Alzheimer's disease (AD) and can be measured using fully automated, random-access platforms. The Elecsys plasma p-tau217 assay requires further validation, particularly in heterogenous populations seen in memory clinics. Objective: To validate plasma p-tau217 in comparison with p-tau181 and to evaluate its association with other soluble core 1 AD biomarkers, as well as markers of neurodegeneration and neuroinflammation. Methods: Biobank data from two prospective blood-based biomarkers validation studies were analyzed. Cerebrospinal fluid (CSF) p-tau181/Aβ 42 ratio served as the reference standard for AD diagnosis. The diagnostic performance of plasma p-tau217 and p-tau181 was compared. In patients with AD, p-tau217 was further evaluated for its association with CSF (Aβ 42 /Aβ 40 ratio, p-tau181, t-tau) and plasma [APOE ε4 protein (APOE ε4p), NfL (neurofilament light chain), GFAP (glial fibrillary acidic protein)] biomarkers. Results: Among 303 patients with mild cognitive impairment or mild dementia, plasma p-tau217 outperformed plasma p-tau181 (AUC 0.93 versus 0.87). By the two threshold diagnostic strategy, an upper cutoff (>0.312 pg/mL, specificity 95%) and a lower cutoff (<0.177 pg/mL, sensitivity 95%) were established, with 27% of cases falling into an indeterminate range. Plasma p-tau217 showed strong correlations with CSF Aβ 42 /Aβ 40 and p-tau181/Aβ 42 ratios, as well as with plasma GFAP, and only moderate correlations with CSF t-tau and p-tau181, and plasma NfL. Conclusions: Plasma p-tau217 measured using Elecsys demonstrates good diagnostic performance and strong associations with other soluble Core 1 AD and neuroinflammation biomarkers.